<doc>
  <docmeta id="113hr4918ih">
    <bill congress="113" type="hr" number="4918" version="ih"/>
    <revision size="2239" annotations="0" status="complete" id="4" commit-time="2014-06-30T13:12:13Z" committer="zwilliams" doc="113hr4918ih/4.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HC166D54D77DC41DF899BB1B004A02781" public-private="public">
	<metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 HR 4918 IH: Speeding Access to Already Approved Pharmaceuticals Act of 2014</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. House of Representatives</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-06-19</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>2d Session</session>
		<legis-num>H. R. 4918</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20140619">June 19, 2014</action-date>
			<action-desc>
        <sponsor name-id="S001187">Mr. Stivers</sponsor> (for himself and <cosponsor name-id="R000577">Mr. Ryan of Ohio</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To require the Food and Drug Administration to expedite review of pharmaceuticals that are approved
			 for marketing in the European Union.</official-title>
	</form>
	<legis-body id="H3CB0F1F30977424DB01A9A18FCEAD3A9" style="OLC">
		<section id="HD54EAD64F9C94DFE9B90AB07AF95AFC1" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the <quote>
          <short-title>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Speeding Access to Already Approved Pharmaceuticals Act of 2014" proposed="true">Speeding Access to Already Approved Pharmaceuticals Act of 2014</cato:entity-ref>
          </short-title>
        </quote>.</text>
		</section>
    <section id="HDF462473014A48958A420C96024878A9">
      <enum>2.</enum>
      <header>Expedited review of EU-approved pharmaceuticals</header>
			<subsection id="HF3494B70ABC545F4BEDB040711CBB686">
        <enum>(a)</enum>
        <header>In general</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:506">Section 506 of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/356">
            <cato:entity-ref entity-type="uscode" value="usc/21/356">21 U.S.C. 356</cato:entity-ref>
          </external-xref>)</cato:entity> is amended by adding at the
			 end the following:</text>
				<quoted-block display-inline="no-display-inline" id="HD4C5911A39CC43BF9A97EACFB6B14297" style="OLC">
					<subsection id="H1B29FA3875174928A7134909DE2A4B71">
            <enum>(g)</enum>
            <header>EU-Approved pharmaceuticals</header>
						<paragraph id="H98B2D7F28B774B6192F4CAC77D6F2B89">
              <enum>(1)</enum>
              <header>Expedited review</header>
              <text>Beginning not later than 90 days after a new pharmaceutical is approved for marketing in the
			 European Union, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall, at the request of the sponsor of the
			 pharmaceutical, facilitate the development and expedite the review of such
			 new pharmaceutical under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505">section 505</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:515">515 of this Act</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:351">section 351 of
			 the Public Health Service Act</cato:entity-ref>, as appropriate.</text>
						</paragraph>
            <paragraph id="HB314F8B2F06240D8AE1C833DBD73E424">
              <enum>(2)</enum>
              <header>Definition</header>
              <text>In this subsection, the term <term>pharmaceutical</term> means a drug (including a biological product) or a device.</text>
            </paragraph>
          </subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</subsection>
      <subsection id="H4C9C7721F3744C6DA233B39DAA4F6C4C">
        <enum>(b)</enum>
        <header>Technical correction</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:506/ss:f">Subsection (f) (relating to awareness efforts) of section 506 of the Federal Food, Drug, and
			 Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/356">
            <cato:entity-ref entity-type="uscode" value="usc/21/356">21 U.S.C. 356</cato:entity-ref>
          </external-xref>)</cato:entity> is hereby moved so as to follow <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:506/ss:e">subsection
			 (e) (relating to construction) of such section 506</cato:entity-ref>.</text>
			</subsection>
    </section>
  </legis-body>
</bill>
</doc>